Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia.
Pan J, Niu Q, Deng B, Liu S, Wu T, Gao Z, Liu Z, Zhang Y, Qu X, Zhang Y, Liu S, Ling Z, Lin Y, Zhao Y, Song Y, Tan X, Zhang Y, Li Z, Yin Z, Chen B, Yu X, Yan J, Zheng Q, Zhou X, Gao J, Chang AH, Feng X, Tong C. Pan J, et al. Among authors: feng x. Leukemia. 2019 Dec;33(12):2854-2866. doi: 10.1038/s41375-019-0488-7. Epub 2019 May 20. Leukemia. 2019. PMID: 31110217 Clinical Trial.
Loss of Lkb1 impairs Treg function and stability to aggravate graft-versus-host disease after bone marrow transplantation.
Su X, Wang Q, Guo W, Pei X, Niu Q, Liu M, Liu Y, Chen S, Feng S, He Y, Yang D, Zhang R, Ma Q, Zhai W, Pang A, Wei J, Huang Y, Luo Y, Han M, Feng X, Jiang E. Su X, et al. Among authors: feng x, feng s. Cell Mol Immunol. 2020 May;17(5):483-495. doi: 10.1038/s41423-019-0312-3. Epub 2019 Oct 29. Cell Mol Immunol. 2020. PMID: 31664223 Free PMC article.
Ruxolitinib mitigates steroid-refractory CRS during CAR T therapy.
Pan J, Deng B, Ling Z, Song W, Xu J, Duan J, Wang Z, Chang AH, Feng X, Tan Y. Pan J, et al. Among authors: feng x. J Cell Mol Med. 2021 Jan;25(2):1089-1099. doi: 10.1111/jcmm.16176. Epub 2020 Dec 12. J Cell Mol Med. 2021. PMID: 33314568 Free PMC article. Clinical Trial.
A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL.
Tan Y, Cai H, Li C, Deng B, Song W, Ling Z, Hu G, Yang Y, Niu P, Meng G, Cheng W, Xu J, Duan J, Wang Z, Yu X, Feng X, Zhou J, Pan J. Tan Y, et al. Among authors: feng x. Blood Cancer J. 2021 Apr 10;11(4):71. doi: 10.1038/s41408-021-00465-9. Blood Cancer J. 2021. PMID: 33839735 Free PMC article. Clinical Trial. No abstract available.
18,219 results
You have reached the last available page of results. Please see the User Guide for more information.